Logo
Secure Registration

International Conference on Pharmacy and Biotechnology Innovations

ICPPBI

27th Feb – 28th Feb 2027 Dublin, Ireland

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

1

Select Registration Mode

2

Participant Details

3

Coupon Code

4

Terms & Condition

Read the full Terms & Conditions

Conference Session Tracks

UN SDG Wheel

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

SDG 3 SDG 4 SDG 9
01 Innovations in Drug Development +
This track focuses on the latest advancements in drug development processes, emphasizing innovative methodologies and technologies. Participants will explore case studies and research that highlight successful drug discovery and formulation strategies.
SDG 3 SDG 4
02 Pharmaceutical Sciences and Their Impact +
This session will delve into the various branches of pharmaceutical sciences, including pharmacokinetics and pharmacodynamics. Discussions will center on how these disciplines contribute to the development of effective therapeutic agents.
SDG 3 SDG 4
03 Medicinal Chemistry: New Frontiers +
This track will examine cutting-edge research in medicinal chemistry, focusing on the design and synthesis of novel compounds. Participants will discuss the implications of these innovations for drug efficacy and safety.
SDG 3 SDG 9
04 Advancements in Pharmacology +
This session will highlight recent breakthroughs in pharmacology, including new drug mechanisms and therapeutic targets. The discussions will emphasize the importance of pharmacological research in improving patient outcomes.
SDG 3 SDG 4
05 Clinical Pharmacy Practices and Innovations +
This track will explore the evolving role of clinical pharmacy in patient care, emphasizing innovative practices and technologies. Participants will share insights on enhancing medication management and patient safety.
SDG 3 SDG 4
06 Therapeutic Innovations in Pharmacy +
This session will focus on novel therapeutic approaches and their applications in pharmacy practice. Discussions will include personalized medicine and the integration of biotechnology in treatment strategies.
SDG 3 SDG 9
07 Pharmacy Technology: Transforming Practice +
This track will examine the role of technology in pharmacy, including automation, data analytics, and telepharmacy. Participants will discuss how these innovations enhance operational efficiency and patient care.
SDG 3 SDG 9
08 Biotechnology Research in Pharmaceutical Sciences +
This session will explore the intersection of biotechnology and pharmaceutical sciences, highlighting research that drives innovation in drug development. Topics will include biopharmaceuticals and gene therapy.
SDG 3 SDG 9
09 Drug Safety and Regulatory Affairs +
This track will address the critical aspects of drug safety and the regulatory landscape governing pharmaceutical products. Participants will discuss best practices for ensuring compliance and protecting public health.
SDG 3 SDG 4
10 Pharmaceutical Research Methodologies +
This session will focus on innovative research methodologies in pharmaceutical sciences, including experimental design and data analysis. Participants will share insights on enhancing research rigor and reproducibility.
SDG 3 SDG 4
11 Future Trends in Pharmacy and Biotechnology +
This track will explore emerging trends and future directions in pharmacy and biotechnology. Discussions will include the implications of artificial intelligence and machine learning in drug development and patient care.
SDG 3 SDG 9